Impact Factor Collection


EJE impact factor graphic

Impact Factor rises above 6!

The European Journal of Endocrinology has achieved its highest impact factor for the fifth year in a row, and passed the 6.000 threshold for the first time. With a 2020 Impact Factor of 6.664, EJE has now climbed to 20th out of 145 journals in the Endocrinology and Metabolism category, standing above many of its broad-scoped, clinical focused competitors, reinforcing its reputation as a global leader for the highest quality research, reviews and guidelines in clinical and translational endocrinology

To celebrate the European Journal of Endocrinology's result the journal Editorial Team has compiled a collection of highly cited articles contributing to the latest Impact Factor.

We would like to thank the world-class editors, authors, reviewers and readers who have all helped EJE grow from strength to strength over recent years, to become a world-leading authority on all areas of clinical endocrinology. Particular thanks go to Editor-in-chief, Professor Wiebke Arlt, whose focus on high-quality, high-impact research from established and emerging areas of clinical endocrinology has facilitated the fantastic achievement of this year’s Impact Factor.




Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis
Panagiotis Anagnostis et al.

Impact of non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) on risk of malignancy in patients undergoing lobectomy/thyroidectomy for suspected malignancy or malignant fine-needle aspiration cytology findings: a systematic review and meta-analysis
Massimo Bongiovanni et al.

Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis
C Nederstigt et al.

Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre
S Asioli et al.

Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma
Sophie Schweitzer et al.

Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study
Martin Kužma et al.

Radiofrequency ablation for benign thyroid nodules according to different ultrasound features: an Italian multicentre prospective study
Maurilio Deandrea et al.

Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence
By A Calabrese et al.

The current landscape of European registries for rare endocrine conditions
S R Ali et al.

Hypoglycaemia is associated with increased risk of fractures in patients with type 2 diabetes mellitus: a cohort study
Antiopi Ntouva et al.




Anorexia nervosa and endocrinology: a clinical update
By René Klinkby Støving

Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans
Aimilia Eirini Papathanasiou et al.

Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency
Anna Nordenström and Henrik Falhammar

Estradiol as a male hormone
Nicholas Russell and Mathis Grossmann

The history of discovery, synthesis and development of testosterone for clinical use
Eberhard Nieschlag and Susan Nieschlag

Endocrine and immunological aspects of burnout: a narrative review
Ingibjörg H Jonsdottir and Anna Sjörs Dahlman

Individualised management of acromegaly
Jens Bollerslev, Ansgar Heck, and Nicoleta Cristina Olarescu

Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society
Paul Lips et al.

Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus
Aliya A Khan et al.

Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus Statement from the first European Society of Endocrinology Workshop (PARAT)
Jens Bollerslev et al.